about
Triple-Modal Imaging of Magnetically-Targeted Nanocapsules in Solid Tumours In Vivo.Carbon nanotubes' surface chemistry determines their potency as vaccine nanocarriers in vitro and in vivoThe interaction of carbon nanotubes with an in vitro blood-brain barrier model and mouse brain in vivoPassively Targeted Curcumin-Loaded PEGylated PLGA Nanocapsules for Colon Cancer Therapy In VivoPhotochemical internalisation of a macromolecular protein toxin using a cell penetrating peptide-photosensitiser conjugate.Polyethylene glycol conjugated polymeric nanocapsules for targeted delivery of quercetin to folate-expressing cancer cells in vitro and in vivo.Kinetics of functionalised carbon nanotube distribution in mouse brain after systemic injection: Spatial to ultra-structural analysesTranslocation of LRP1 targeted carbon nanotubes of different diameters across the blood-brain barrier in vitro and in vivoDual stimulation of antigen presenting cells using carbon nanotube-based vaccine delivery system for cancer immunotherapyInvestigating the effect of tumor vascularization on magnetic targeting in vivo using retrospective design of experiment.In vitro potency, in vitro and in vivo efficacy of liposomal alendronate in combination with γδ T cell immunotherapy in mice.Real-time monitoring of magnetic drug targeting using fibered confocal fluorescence microscopy.Engineering hepatitis B virus core particles for targeting HER2 receptors in vitro and in vivo.Mixed micelles of lipoic acid-chitosan-poly(ethylene glycol) and distearoylphosphatidylethanolamine-poly(ethylene glycol) for tumor delivery.Functionalised carbon nanotubes: From intracellular uptake and cell-related toxicity to systemic brain delivery.Cationic Liposome- Multi-Walled Carbon Nanotubes Hybrids for Dual siPLK1 and Doxorubicin Delivery In Vitro.Multiphoton luminescence imaging of chemically functionalized multi-walled carbon nanotubes in cells and solid tumors.Current Perspective of Carbon Nanotubes Application in Neurology.The relationship between the diameter of chemically-functionalized multi-walled carbon nanotubes and their organ biodistribution profiles in vivo.Investigating in vitro and in vivo αvβ6 integrin receptor-targeting liposomal alendronate for combinatory γδ T cell immunotherapy.Solvent-Free Click-Mechanochemistry for the Preparation of Cancer Cell Targeting Graphene Oxide.Magnetic Drug Targeting: Preclinical in Vivo Studies, Mathematical Modeling, and Extrapolation to Humans.Spatially-resolved profiling of carbon nanotube uptake across cell lines.Polymeric glabrescione B nanocapsules for passive targeting of Hedgehog-dependent tumor therapy in vitro.The Shortening of MWNT-SPION Hybrids by Steam Treatment Improves Their Magnetic Resonance Imaging Properties In Vitro and In Vivo.Chitosan Glutamate-Coated Niosomes: A Proposal for Nose-to-Brain Delivery.Nano-technology based carriers for nitrogen-containing bisphosphonates delivery as sensitisers of γδ T cells for anticancer immunotherapy.Functionalized carbon nanotubes: revolution in brain delivery.Designed inorganic porous nanovector with controlled release and MRI features for safe administration of doxorubicinDesign of antibody-functionalized carbon nanotubes filled with radioactivable metals towards a targeted anticancer therapyEngineering red-emitting multi-functional nanocapsules for magnetic tumour targeting and imaging
P50
Q27300994-E1C22B0F-3C6E-46B3-9AC6-E4946271A02FQ28388765-95D860D2-09EE-4748-B1D5-0165C8E980FBQ28392435-A4B829EF-8A8D-4691-9996-A29FBCFF6F06Q30978432-E237F422-EBB7-4432-A830-7F012E1B86B4Q34010471-FBA021F5-48D4-4783-97BA-EB40C1D54427Q35084470-1D4479AD-DFFB-4D76-A93D-28009DE3EEEEQ36587432-CAE3F1CF-BED7-4D60-BD72-608DDD33956CQ36652635-BAD302ED-0EF0-4D59-9E2B-4846A676C704Q37195052-F6478C75-C4AB-41C8-A352-1787DA57B5E6Q37265298-AD02EA0E-1606-4B0B-9D30-5F34CF9AF568Q37354985-2BB745A9-EDAC-4F8A-9772-D37E779D6BA1Q37524376-5B73F56B-52C9-4BF1-9D36-A6524E2EC382Q37634520-C43DD2BA-6BF9-4CD5-870C-1F58F705EE62Q38717866-29DE4D42-C6FC-46E6-B5AD-4A42F7EA093DQ38810360-D50079C9-5ED3-47F9-8A46-962E874CC45CQ38862852-F8A05A42-DF9E-4453-A2F5-BC493FEB20C7Q38877105-51C525A0-A3B0-4C9B-B683-59FA5B4FE206Q38966376-AF6E8B12-623D-4E9A-ADEB-B29CA6E54A7DQ39138157-2BA99F81-ABD0-4957-8032-6B1675D5FC38Q41016131-7D0A615C-D606-439E-BE1C-BFFB7923990BQ42581528-13986184-D3D6-46DD-AE79-A4B15EAE4B35Q50594095-9F930BD6-1FEC-470F-B26F-FE00C40A4143Q50881477-7B4FC74F-3FB9-40E9-9DD3-C2F13B1FF9F0Q51092808-CAA4F613-D940-466B-9039-F6E758C9D7F3Q51370997-43C1F9E2-AD54-4220-A511-1BD5DCF5C561Q51732339-A0F2D6F0-4C7C-480B-8894-307539879AA6Q51842829-90D897E4-939B-4B2C-868E-D3C0BCF78C5DQ52150149-283D1683-5C3E-48A3-99FB-FD80E8CC095CQ58555508-84A3244E-F4CF-4BE6-A457-94F7D2300C70Q59652010-829CF57E-1165-4D3B-994C-C5423C52A339Q90836647-8E56A0E3-CE6C-40BC-9F0F-AFD75267008A
P50
description
investigador
@es
researcher
@en
name
Julie T-W Wang
@en
type
label
Julie T-W Wang
@en
prefLabel
Julie T-W Wang
@en
P31
P496
0000-0001-5956-0123